Search Results for: Tuberculosis

Johnson & Johnson Offers Global Access by Not Enforcing Sirturo’s Tuberculosis Drug Secondary Patents

by
Johnson & Johnson Offers Global Access by Not Enforcing Sirturo’s Tuberculosis Drug Secondary Patents

Johnson & Johnson has taken significant steps to improve access to its multidrug-resistant tuberculosis (MDR-TB) medication, Sirturo (bedaquiline), in low- and middle-income countries. The company has allowed generic competition and reduced the price of Sirturo, making it more affordable in these regions. In an even more commendable move, Johnson & Johnson has now committed to … Read more

Siemens Healthineers and Qure.ai to deploy AI-powered chest X-ray screening for TB

by
Siemens and Qure.ai team up for TB screening

Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, is intensifying efforts to harness artificial intelligence in the battle against tuberculosis (TB), an infectious disease that continues to plague communities globally. This strategic initiative focuses on the widespread adoption of AI and machine learning programs capable of swiftly … Read more

ImmunityBio cuts 50 jobs in California and Florida after FDA snubs its bladder cancer drug

by
immunitybio layoffs california florida, immunitybio anktiva fda rejection, immunitybio bladder cancer drug cll, immunitybio contract manufacturing issues, immunitybio cost reduction strategy, immunitybio anktiva approval status, immunitybio bladder cancer market

Following an FDA rejection earlier this year, ImmunityBio has initiated its second round of layoffs in less than a year, affecting approximately 50 employees across its California and Florida locations. The layoffs, as reported in a September 19 California Worker Adjustment and Retraining Notification (WARN) report, involve 48 job cuts, primarily impacting employees based in … Read more

J&J cuts TB drug price by 55% after giving up patent rights 

by
Johnson & Johnson, tuberculosis, patent rights, generic competition, Sirturo, bedaquiline

Just seven weeks after announcing its willingness to permit generic competition for the drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low- and middle-income countries (LMICs), Johnson & Johnson (J&J) has taken a remarkable step by significantly reducing the price of its own drug in those markets. In a groundbreaking move, J&J has adjusted the pricing … Read more

UK establishes ‘100-day’ rapid-response vaccination unit

by
UK Launches Rapid Vaccine Unit to Fight Future Pandemics

The UK government has formally inaugurated an advanced vaccine research center situated within the UK Health and Security Agency (UKHSA) in order to enhance the nation’s readiness for future pandemics. The newly established facility, located at the UKHSA site in Porton Down near Salisbury, Wiltshire, is staffed by over 200 scientists who are focused on … Read more

Pharmtales - your go-to source for comprehensive coverage of the pharmaceutical industry.

pharmtales
Latest Pharma News & Insights

© 2024 pharmtales.com | All rights reserved.

PRIVACY POLICY terms of service Contact us